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The γ subunit of the major histocompatibility complex (MHC) class II complex, CD74, is overexpressed in a significant
proportion of metastatic breast tumors, but the mechanistic foundation and biologic significance of this phenomenon
are not fully understood. Here, we show that when CD74 is overexpressed in human cancer and noncancerous
epithelial cells, it interacts and interferes with the function of Scribble, a product of a well-known tumor suppressor
gene. Furthermore, using epithelial cell lines expressing CD74 under the control of tetracycline-inducible promoter
and quantitative high-resolution mass spectrometry, we demonstrate that, as a result of CD74 overexpression, the
phosphorylation pattern of the C-terminal part of Scribble undergoes specific changes. This is accompanied with a
translocation of the protein from the sites of cell-to-cell contacts at the plasma membrane to the cytoplasm, which is
likely to effectively enhance the motility and invasiveness of the cancer cells.
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Cancer metastasis is a multistage process that is governed by a complex
program of gene expression and signal transduction that ultimately
allows the metastasizing cells to invade surrounding stroma, travel
through the circulation, and colonize distant sites. This program se-
quentially switches specific genes on and turns others off, effectively
exerting very dramatic changes of the abundance of many hundreds
of proteins in the cell. Since the completion of the human genome proj-
ect, post-genomic approaches based on application of oligonucleotide
microarrays and next-generation sequencing are beginning to shed light
on the global cancer genomics landscape and its molecular landmarks.
In addition, developments in quantitative proteomics now allow us
to dig even deeper: to map the posttranslational modifications and
protein-protein interactions that are at the core of the regulation of
the molecular mechanisms that drive metastasis. In this study, we
applied one such quantitative proteomics approach to investigate the
role of CD74 in promoting metastasis of triple-negative breast cancer,
a particularly malignant type of the disease.CD74, the γ subunit of the major histocompatibility complex
(MHC) class II complex, is frequently overexpressed in malignant
tumors of epithelial and mesenchymal origin. The protein has been
suggested as a potential target for rationale-based therapies of lym-
phoma and multiple myeloma and therapeutic agents targeting CD74
or components of its signaling cascade are in advanced stages of clinical
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overexpression is linked to increased invasion and metastasis of breast
tumors, particularly the tumors of the triple-negative phenotype [4,5].
CD74 is a chaperone protein with an important role in innate
immunity. It is required for the expression and functions of the
MHC class II receptors and, in addition, has been implicated in cyto-
kine and survival signaling [6–8]. However, the mechanistic founda-
tion for the apparent CD74-augmented malignancy of triple-negative
breast tumors is not known. To address this, we have engineered
human epithelial cells to express CD74 under the control of a highly
regulated inducible promoter, which allowed us to study the effect of
CD74 overexpression on protein abundance and protein phosphoryla-
tion at a system-wide scale. We found that when overexpressed, CD74
affects the phosphorylation state and function of Scribble, a product
of the well-known tumor suppressor gene scrib, which is crucial for
the proper maintenance of epithelial cell integrity and function and
which is frequently deregulated in breast cancer [9]. Scribble func-
tion in maintaining polarity was first discovered in Drosophila. Bilder
et al. found that scrib mutations cause aberrant cell shape and loss of
monolayer organization in epithelia [10] and that scrib acts as a tumor
suppressor [11]. In human cells, Scribble is required for E-cadherin–
mediated cell-cell adhesion, and when its expression is downregulated,
epithelial cells acquire mesenchymal appearance and their migration is
augmented [12].
Materials and Methods
Unless indicated otherwise in the text, chemicals and HPLC solvents
were purchased from Thermo Fisher (Loughborough, United Kingdom).
The highest available grades were used.
Cell Culturing
Breast cancer cell lines MDA-MB-435, MDA-MB-231, MCF7, and
ZR-75.1 and human embryonic kidney 293T/s (HEK293T/s) were
grown on RPMI 40 Ultraglutamine medium supplemented with
10% fetal calf serum at 37°C and 5% CO2 and split every second
day. The cells were grown to about 80% confluency, detached, washed
with phosphate-buffered saline (PBS), and stored at −80°C until needed
for analysis.
SILAC Labeling
The cell cultures were labeled using the SILAC Labeling Kit from
Thermo Fisher following the manufacturer’s instructions and as de-
scribed by Ong et al. [13]. All cell cultures were labeled for at least five
doubling times to ensure complete protein labeling.
Transient Transfection
This was performed as previously described using HEK293T and
MCF7 cells [5].
Generation of Stably Transfected HEK293s Cells Expressing
CD74 under the Tetracycline-Inducible Promoter
To generate these cell lines, we used an HEK293s derivative stably
transfected with the TetR construct and expressing the repressor
(HEK293s-TetR) [14]. The cells and the TetO plasmid were kind gifts
fromDr Phil Reeves from the University of Essex. The CD74 sequence
was subcloned into the TetO plasmid using the following primers:
FOR: 5′-GGAATTCGCCACCATGCACAGGAGGAGAAGCAG-3′
REV: 5′-GCGGCCGCTCACATGGGGACTGGGCCCAGATCC-3′from a construct described previously and using the same cloning
strategy as described by Reeves et al. for rhodopsin [14]. The TetO-
CD74 plasmid was sequenced to validate the sequence and then
transfected in to the HEK293s-TetR cells. The transfectants were
selected on G418-containing medium for about 3 weeks until G418-
resistant TetR/TetO colonies could be isolated. Twelve colonies
were isolated initially, and after screening for inducible CD74 ex-
pression, five positive colonies were expanded and stored as stock for
further experiments.
CD74 Overexpression and Knockdown
The TetR/TetO-CD74 HEK293s cells were induced with 1 μg/ml
tetracycline for various periods of time. An untreated TetR/TetO-
CD74 control was mock treated for the same periods of time. An
additional control with TetR HEK293s cells treated with tetracycline
was also included in most of the experiments to identify possible
tetracycline-induced phenomena that are independent of CD74.
CD74 knockdown in MDA-435-MB cells was performed using
siRNA from Santa Cruz Biotechnology (Santa Cruz, CA) according
to the manufacturer’s instruction.
Tumor Tissue Acquisition
All tissues were collected under Local Research Ethics Committee
(LREC) and National Health Services (NHS) Trust approval as pre-
viously described [5,15]. Tumor tissue was placed on ice immedi-
ately in the operating theater. The tissue was assessed and cut by
the pathologist on ice before being divided up with a proportion of
the tissue snap frozen in liquid nitrogen and the remainder fixed in
formalin with the shortest possible delay.
Membrane Protein Isolation
Approximately 20 to 50 mg of frozen tissue from a surgery specimen
or core biopsy was snap frozen in liquid nitrogen and pulverized in
a BioPulverizer stainless steel device (BioSpec Products, Bartlesville,
OK). The homogenized sample was placed on ice and mixed with
500 μl of permeabilization solution containing PBS, 0.2% saponin,
and protease and phosphatase inhibitors (Roche Diagnostics, Burgess
Hill, United Kingdom). For cultured cells, the homogenization step
was omitted and the cells were directly permeabilized. The samples
were incubated on ice with intermittent mixing for 15 minutes and
centrifuged at 14,000 rpm in a refrigerated centrifuge for 45 minutes.
Following centrifugation, the supernatant containing the water-soluble
proteins was removed and stored frozen until needed. The pellet was
washed with 500 μl of PBS containing protease and phosphatase inhib-
itors and centrifuged as above. The washed permeabilized pellet was
extracted with 100 μl of membrane protein extraction buffer containing
1% (vol/vol) IGEPAL in 50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
and protease and phosphatase inhibitors as above, resuspended, and
incubated on ice for 10 to 15 minutes. Cultured cells were extracted
in 1 ml of buffer per 107 cells. The sample was then centrifuged at
4°C and 14,000 rpm for 15 minutes. The supernatant containing the
membrane proteins was recovered and either processed immediately as
described below or stored at −80°C until needed.
Immunoprecipitation
Membrane protein fractions extracted as above containing about
0.5 mg of total protein (estimated by dye-binding assay) were di-
luted 1:1 with binding buffer containing 50 mM Tris-HCl (pH 7.4)
and 150 mM NaCl and incubated with 6 μg of LN2 antibody for
662 CD74 and Scribble in Breast Cancer Metodieva et al. Neoplasia Vol. 15, No. 6, 201330 minutes at room temperature to allow antibody binding to the
CD74 extracellular domain. To each tube, 60 μl of protein A/G agarose
(Santa Cruz Biotechnology) prewashed with 1 ml of binding buffer was
then added. The tubes were further incubated for 1 hour at room tem-
perature on a rotator. We found that because of the inclusion of pro-
tease and phosphatase inhibitors in the membrane extraction buffer,
performing the experiments at room temperature gave better yields
and throughput. The agarose beads were washed three times with
binding buffers and the precipitated proteins eluted with 30 μl of
sodium dodecyl sulfate sample buffer containing 12 mM DTT for
5 minutes at 100°C. The samples were then cooled on ice and alkylated
with 60 mM iodoacetamide for 30 minutes in the dark. For Western
blot analysis, an aliquot of the sample was separated by denaturing
polyacrylamide gel electrophoresis (PAGE) and transferred onto a poly-
vinylidene fluoride (PVDF) membrane. For immunoprecipitation/mass
spectrometry (IP/MS) analysis, the sample was separated and the gel
sliced into five size-resolved fractions, digested with trypsin, and analyzed
by liquid chromatography/tandem mass spectrometry (LC-MS/MS).
Protein Digestion and Preparation of Samples for
Mass Spectrometry
The protein samples were mixed with 2× sodium dodecyl sulfate
sample buffer, reduced, alkylated, and subjected to in-gel digestion as
previously described [15]. The SILAC-labeled proteins were separated
into up to 10 fractions by a semipreparative PAGE before digestion.
Isolation of Phosphopeptides
Aliquots containing about 0.5 mg of total protein were separated by
a semipreparative PAGE on single-well minigel. Up to 10 size-resolved
fractions were excised and digested as described above. The tryptic
peptides were extracted from the gel pieces, and 10% of the extracted
peptides were removed for quantitative analysis of protein abundance
and dried in a vacuum concentrator. The remaining 90% were also
dried and dissolved in 100 μl of 80% acetonitrile containing 2% formic
acid and used to isolate phosphorylated peptides. Phosphopeptides
were isolated using the Magnetic TiO2 Phosphopeptide Isolation Kit
from Thermo Fisher following the manufacturer’s instructions.
Nanoscale LC-MS/MS Analysis
Protein digest analysis by electrospray ionization MS was per-
formed on a hybrid LTQ/Orbitrap Velos instrument (Thermo Fisher)
interfaced to a splitless nanoscale HPLC (Ultimate 3000; Dionex,
Loughborough, United Kingdom). The peptides were desalted and
concentrated online at a flow of 1 μl/min on a 2-cm-long, 0.1-mm
i.d. trap column packed with 5-μm C18 particles (Dionex). Following
concentration/desalting, the peptides were eluted from the trap column
and separated in a 90-minute gradient of 2% to 30% (vol/vol) aceto-
nitrile in 0.1% (vol/vol) formic acid at a flow rate of 0.3 μl/min. The
separation column was a 15-cm-long, 0.1-mm i.d. pulled tip packed
with 5-μm C18 particles (Nikkyo Technos Co, Tokyo, Japan). The
eluting peptides were electrosprayed directly from the packed tip into
the LTQ/Orbitrap Velos mass spectrometer by applying 1.75 kV
through a liquid junction interface. The LTQ/Orbitrap Velos was
operated in the Top 20 data-dependent mode where it first executes
two high-resolution scans at a resolution of 30,000 (at 400 m/z) fol-
lowed by 20 MS/MS scans for the 20 most abundant peptide ions hav-
ing a charge state > 1. During the high-resolution scans, the Orbitrap
analyzer was set to accumulate 106 ions for the maximum of 0.5 sec-
ond. During MS/MS scans, the LTQ was set to accumulate 5000 pre-cursor ions for the maximum of 0.1 second. The normalized collision
energy was set to 30; minimum signal intensity required was set to
500, activation time to 10 milliseconds, and activation Q to 0.250. A
dynamic exclusion procedure was implemented to avoid repetitive anal-
ysis of abundant peptide ions: After a peptide ion has been analyzed
once, its m/z was put in the exclusion list for 30 seconds. The mass
calibration was internal by means of lock mass. The ambient ion of
445.12 m/z was used for this purpose throughout all experiments. For
targeted detection of Scribble peptides, a mixed mode analysis was
used in which a full scan was performed as described above; the next
four selected reaction monitoring (SRM) scans were performed to
isolate and fragment two Scribble reporter peptides, VSLVGADDLR
and VQSPEPPAPER, in their heavy and light SILAC isoforms. Fi-
nally, seven data-dependent MS/MS scans were performed to isolate
and fragment the seven most abundant peptide ions detected in the
high-resolution full scan.Data Analysis
MS/MS data were analyzed by MaxQuant and the Andromeda
search engine as described in [16–18]. The MaxQuant searches were
performed using a reverse database to calculate false discovery rate
(FDR). Results from the Andromeda engine were filtered at both pep-
tide and protein level. In both cases, the cutoff was at 1% FDR. For
SILAC ratios of unmodified peptides and phosphopeptides, the quan-
titative analysis was performed by MaxQuant and further evaluated by
statistical tests using Microsoft Excel.Western Blot Analysis and Immunohistochemical Analysis
of Tumor Tissue
Immunoblot analysis and immunohistochemistry were performed
as previously described [15]. For CD74 detection in immunohisto-
chemical (IHC) and for immunoprecipitation, the mouse monoclonal
antibody LN2 from Santa Cruz Biotechnology was used. β-Tubulin and
Scribble antibodies were also from Santa Cruz Biotechnology. IHC
staining was scored using the immunoreactivity score (IRS) scores as im-
plemented for Her2 staining, taking into account staining intensity and
the percentage of positive cells: intensity ranges from 1 to 3 for weak,
moderate, and strong staining, respectively. Percentage ranges from 1 to
5 for <10%, 10% to 25%, 25% to 50%, 50% to 75%, and >75%
staining of the malignant cells; total score = intensity + percentage.Indirect Immunofluorescence and Colocalization Analysis
Cells to be analyzed were grown in eight-well chamber slides
(Lab-Tek; Fisher Scientific, Loughborough, United Kingdom), treated
and fixed in 4% buffered paraformaldehyde, and permeabilized in PBS
containing 0.5% Triton X-100 for 5 minutes. The cells were blocked
in 5% BSA in PBS for 1 hour and stained with mouse anti-Scribble
antibody and rabbit anti-CD74 antibody (1:100 dilution) diluted in
PBS containing 1% BSA for 1 hour at room temperature (RT). The cells
were washed three times in PBS containing 0.1% (vol/vol) Tween 20.
The cells were then incubated with secondary antibody solution contain-
ing goat anti-mouse Cy5 (Abcam, Cambridge, United Kingdom) and
goat anti-rabbit fluorescein isothiocyanate (Abcam), diluted 1:1000 in
PBS containing 1% BSA and 0.1% Tween 20 for 45 minutes. The cells
were then washed three times in PBS containing 0.1% Tween 20 and
analyzed by laser scanning confocal microscopy on a Nikon Eclipse Ti
microscope. Colocalized pixels were identified using the ImageJ plugin
ColocalizeRGB.
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The cells were stained as above and counted in a BD FACS Aria
instrument. A secondary antibody-only control was included to estimate
nonspecific staining.Results
In a previous study, we found that CD74 is more abundant in lymph
node–metastatic triple-negative tumors compared to nonmetastatic
triple-negative breast cancer (TNBC) tumors. This conclusion was
based on data obtained bymass spectrometry and pooled tumor proteinFigure 1. CD74 overexpression affects the pattern of posttranslational
map of Scribble based on a cartoon from the SMART database sho
the protein affected by CD74 overexpression in HEK293 and MCF7
phosphoproteomics screens using transiently transfected MCF7 an
CD74 under the control of tetracycline-inducible promoter. (B) Sca
LC-MS/MS analysis. The normalized heavy-to-light ratios are plotted aga
a set of phosphopeptides that center around H /L ratio of 1, which are
tains the phosphopeptides that are strongly decreased in the CD74-
t test using the normalized H /L ratios of the two clusters indicated by
peptide ions showing large difference between the intensities of the
overexpressing cells. The phosphopeptide sequences are indicated ulysates from six metastatic and six nonmetastatic triple-negative breast
tumors [5]. Since this analysis did not discriminate between expres-
sion in the malignant cells and other cells in the tumor, we decided
to reexamine CD74 expression in another collection of triple-negative
breast tumors, this time using immunohistochemical staining instead of
mass spectrometry. The results, shown in Figure W1 in the Supple-
mentary information available online, confirmed the previously re-
ported observation that CD74 tends to be more abundant in lymph
node–metastatic triple-negative breast tumors. We stained 9 node-
positive tumors and 10 node-negative tumors. Seven of the node-
positive tumors showed strong CD74 staining in the malignant cells,modifications of the tumor suppressor protein Scribble. (A) Domain
wing the four phosphorylation hotspots in the C-terminal part of
cells. The three sites were identified in quantitative proteomics/
d HEK293 cells and stably transfected HEK293s cells expressing
tterplot of Scribble phosphopeptides detected by high-resolution
inst the Andromeda score. Two clusters of data points are apparent:
not affected by CD74 overexpression, and another cluster that con-
overexpressing cells. The P value was calculated by the Student’s
gray borders. (C) Zoom-in of the isotope envelops of two phospho-
light peptide ions and the heavy counterparts deriving from CD74-
nder the spectra.
Figure 2. Scribble is mislocalized in CD74-overexpressing cells. Laser scanning confocal images of control and transfected MCF7 and
HEK293 cells stained with mouse monoclonal anti-Scribble primary antibodies and anti-mouse fluorescein isothiocyanate conjugate.
Representative focal planes taken from the midsection of the cells are shown.
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This corresponds to a P value of .0409 by the nonparametric Mann-
Whitney t test, indicating that aberrant CD74 expression in the malig-
nant cells is associated with increased metastasis. A similar pattern was
observed when various established breast cancer cell lines were studied
for CD74 expression: The most metastatic line, MDA-435-MD, was
the only one to show constitutive CD74 expression. All other tested cell
lines did not express the protein normally at detectable level, although
some of them could be induced to express small amounts if treated
with interferon γ ([4,5]; Supplementary information). To investigate
whether CD74 expression contributes to invasion of MDA-435-MB
cells, we used siRNA to knock down CD74 and performed wound
healing assays. Indeed, when the expression of CD74 was down-
regulated by siRNA, the wound healing ability of MDA-435-MB cells
was diminished (Supplementary information, Figure W2). Thus,
tumor specimen analysis and in vitro experiments with cultured cells
provided additional evidences for the involvement of CD74 in the
invasion and metastasis of breast cancer.
To identify likely targets of CD74 in this context, we decided to fol-
low a quantitative approach based on stable isotope labeling, in which
total protein abundance and protein phosphorylation were quantified
simultaneously in cells engineered to express the protein in a highly
regulated way. This allowed the identification of phosphorylation
hotspots: protein phosphorylation sites that are significantly affected
by CD74 overexpression while the corresponding total protein abun-
dances are not. This combined genome-scale proteomic screen pin-
pointed the tumor suppressor protein Scribble as a likely target of
CD74 in breast cancer. While the total amount of Scribble, as mea-
sured by quantitative high-resolution mass spectrometry, did not
change dramatically after 24 hours of CD74 expression, three spe-
cific phosphopeptides decreased significantly in the cells overexpressing
CD74. Figures 1 and W3 illustrate the results obtained using HEK293s
cells expressing CD74 under the control of a tetracycline-inducible
promoter. Similar results were obtained in transiently transfected MCF7cells. Three of the phosphorylation sites on two of the phosphopeptides
conform well to the canonical mitogen-activated protein kinase
(MAPK) phosphorylation consensus, P-X-S/T-P, and have been de-
tected previously in large-scale phosphoproteomics studies [19,20].
The third peptide is also phosphorylated on a proline-directed site
and could be either MAPK or cyclin-directed kinase target.
Following the identification of Scribble as likely target of CD74, we
examined its intracellular localization in control HEK293T andMCF7
cells and in cells transiently transfected with a construct encoding full-
length CD74. Strikingly, in the transfected cells, Scribble appeared to
change its typical localization at the adherence junctions and translocate
to the cytoplasm. This is shown in Figure 2. In the stably transfected
HEK293s cells, the protein did not change localization as dramatically
after 24 hours of induction, but its immunoreactivity increased and the
CD74-expressing cells consistently showed significantly higher fluores-
cence in confocal images (Figure 3C). This increased immunoreactivity
was reproduced in FACS experiments (Figure 3B) but not in Western
blot analyses (Figure 3A).
To shed more light on the underlying mechanisms, we then asked
whether CD74 and Scribble interact and/or colocalize in the stably
transfected cells. Binding of CD74 to a particular part of Scribble
might, for example, prevent the interaction of Scribble with a third
protein and effectively ensure that the epitope recognized by the anti-
Scribble antibody is exposed and detectable in immunofluorescence
and FACS experiments. Indeed, in both co-IP/Western blot and
co-IP/MS experiments, CD74 and Scribble copurified as shown in
Figure 4.We first performed co-IP/Western blot experiments, in which
CD74 was immunoprecipitated using an antibody recognizing its
extracellular part. The immunoprecipitated proteins were probed with
anti-Scribble antibody and a band with the same electrophoretic
mobility as Scribble was detected only in the co-IP from cells over-
expressing CD74 but not from control uninduced cells (Figure 4A).
To rule out any possibility that this result might have been due to
a nonspecific binding or antibody cross-reactivity, we performed
Figure 3. Scribble expression in stably transfected HEK293s cells expressing CD74 under the control of tetracycline-inducible promoter.
(A) Western blot analysis showing the same Scribble abundance in the fully denatured and unfolded samples extracted from control
and tetracycline-induced cells. (B) The same cell cultures as in A show increased Scribble staining in the CD74-overexpresing cells in
FACS assays despite the fact that the same anti-Scribble primary antibody is used. The filled-in gray histogram is from secondary
antibody-only control. (C) The same cell cultures as in A and B show increased Scribble staining by confocal microscopy. The same
primary antibody is used.
Figure 4. Scribble and CD74 copurify from membrane protein isolates and colocalize in stably transfected HEK293s cells. (A) Co-IP/Western
blot analysis. Scribble is detected only in the CD74 IP from cells induced with tetracycline to express CD74. (B) Co-IP/MS. Themultiple reaction
monitoring (MRM) signal for the reporter peptides is normalized to 100. The values are mean of three replicate LC-MS/MS analyses ± SD. This
experimentwas performed twice. First, CD74 expressionwas induced in the heavy SILAC-labeled cells. Then, the proteinwas overexpressed in
the light SILAC-labeled cells. In both experiments, MaxQuant detected Scribble peptides only in the CD74 IP from tetracycline-induced cells.
(C) Colocalization of Scribble and CD74 in HEK293s cells overexprerssing CD74.
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around the quantitative SILAC technology; its implementation for
protein interaction analysis is described by Blagoev et al. [21] and took
advantage of the high sensitivity and mass accuracy of the hybrid
LTQ/Orbitrap technology. To ensure quantitative precision and rule
out false-positive results, the co-IP/MS experiments were performed
twice independently and in the following manner: In the first experi-
ment, we labeled one cell culture with heavy arginine and lysine and
had another cell culture grown on light amino acids. We then in-
duced CD74 expression for 24 hours in the heavy-labeled culture but
left the light-labeled culture uninduced. Then, CD74 was immuno-
precipitated from both cell cultures under identical conditions and
using equal total protein amounts. The proteins immunoprecipitated
from “heavy” and “light” cultures were mixed, separated by denatur-
ing PAGE, digested with trypsin, and analyzed by high-resolution
LC-MS/MS. To increase the sensitivity of detection, we performed
a mixed mode data-dependent/targeted analysis. This allowed a very
precise quantitative assessment of the ability of CD74 to coimmuno-
precipitate Scribble. In the alternative labeling experiment, this pro-
cedure was repeated but in reverse: The light-labeled culture was
induced with tetracycline, while the heavy-labeled sample was left
uninduced. The results from these experiments are shown in Fig-
ure 4B. In both assays, Scribble reporter peptides were only de-
tected in the CD74 IP from the induced samples but not from the
uninduced samples.
Thus, CD74 and Scribble copurify, which suggests that the two
proteins might interact physically, either directly or through a third
protein. If this is the case and the interaction takes place in vivo, then
subpopulations of CD74 and Scribble molecules should also be seen
at the same sites in the cells. We therefore asked whether the two pro-
teins colocalize and performed double-labeling immunofluorescence
experiments to test this hypothesis. The results, illustrated in Figure 4C ,
show that, indeed, this is the case and portions of the pools of the two
proteins clearly colocalize in the CD74-overexpressing cells.
In another independent line of investigations, we transfected TetO-
CD74 HEK293 cells with a green fluorescent protein (GFP)-tagged
Scribble construct and asked whether GFP-Scribble would changeFigure 5. Overexpression of CD74 induces translocation of a subpopu
side of the cells. GFP-Scribble was transiently transfected in TetO-C
tetracycline. After 24 hours of induction, the cells were fixed and sta
focal microscopy. The image is presented as “Slice View,” in which th
XZ are formed by slicing the stack as indicated by the crossed orang
GFP-Scribble can be seen only in the cells overexpressing CD74.localization when the expression of CD74 is turned on by tetracycline.
The results from these experiments are illustrated in Figure 5. The
GFP-Scribble reporter localized to the basolateral parts of the mem-
brane in the uninduced cells and was never seen on the apical side of
the cell. In contrast, when CD74 was overexpressed for 24 hours, GFP-
Scribble clearly appeared at the apical side of the cells. This was also
seen in indirect immunofluorescence experiments, in which we stained
endogenous Scribble with a monoclonal antibody as in the experiments
presented in Figure 4 and examined its localization by confocal micros-
copy (data not shown).Discussion
In recent tumor proteomics study focusing on triple-negative breast
cancer, we identified CD74 as frequently overexpressed in the lymph
node–metastatic tumors [5]. Here, we show that when CD74 is over-
expressed in cultured epithelial and cancer cells, the phosphorylation
state of several sites in the C-terminal part of the tumor suppressor
protein Scribble changes significantly. The corresponding phos-
phopeptides were detected and quantified by high-resolution mass
spectrometry using SILAC-labeled cells. Altogether, we mapped
19 different Scribble phosphorylation sites and also quantified a large
number of unmodified Scribble peptides. This enabled statistical
analysis that pinpointed four phosphorylation sites as hotspots—
phosphorylations that change significantly in response to CD74
overexpression. Three of these sites conform to the canonicalMAPK con-
sensus, which is intriguing as CD74 was previously implicated in an
MAPK signaling: As a cellular receptor for the cytokine macrophage
inhibitory factor (MIF), CD74 was shown to interact and activate
the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular
signal-regulated kinase (ERK) cascade [6].
Furthermore, Scribble localization changed and apparent immuno-
reactivity increased in cells overexpressing CD74 (Figure 2). Conceiv-
ably, there could be at least three explanations for this increased
immunoreactivity: 1) Scribble protein abundance might be upregulated
in response to CD74 overexpression; 2) the epitope recognized by the
anti-Scribble antibody could overlap with and be masked by thelation of Scribble molecules from the basolateral side to the apical
D74 HEK293s cells and the expression of CD74 was induced with
ined with anti-CD74 antibody and analyzed by laser scanning con-
e three orthogonal planes XY (the midsection of the stack), YZ, and
e lines. The white arrows point to the apical side of the cells where
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mean that overexpression of CD74, by decreasing the phosphorylation
on these sites, would increase the immunoreactivity of Scribble; 3) the
epitope is masked by a protein that binds to it in the control cells, but
this interaction is disrupted in CD74-overexpresing cells.
The first model is immediately disproved because the SILAC
analysis showed no significant change in total Scribble after 24 hours
of tetracycline treatment. A Western blot analysis confirmed this (Fig-
ure 3A), although in cells induced for longer periods of time Scribble
abundance did decrease moderately (Figure W4). Thus, CD74 over-
expression increased the immunoreactivity of native Scribble but did
not affect it in Western blots where the protein is fully unfolded and
denatured. The Western blot results also disprove the second model:
If increased Scribble immunoreactivity in the CD74-overexpressing
cells was due to a hypophosphorylated epitope, it is likely that it would
have shown up in the Western blot results as well. Thus, the only
valid model is explanation 3, which assumes, for specific changes in
the network of protein-protein interactions of Scribble, its immediate
molecular microenvironment. This is consistent with the fact that
Scribble appeared to change localization when CD74 was overexpressed
(Figures 2 and 5).
Furthermore, when overexpressed, CD74 was able to coimmuno-
precipitate Scribble and was seen to colocalize with a subset of Scrib-
ble molecules (Figure 4).
Taken together, our results show that when overexpressed, CD74
engages in a functional interaction with Scribble, which initially af-
fects not only the total abundance of Scribble but also the pattern of
its posttranslational modifications in the C-terminal part of the pro-
tein. This, by as yet to be elucidated mechanisms, causes the tumor
suppressor protein to shift its localization from the basolateral mem-
brane and the sites of cell-to-cell contacts to the cytoplasm and the
apical membrane. Apparently, this also leads to a down-regulation
of Scribble in the long run as the protein abundance decreased after
48 hours of induced CD74 expression (see Figure W4 available
online). Thus, when CD74 is overexpressed for a prolonged period
of time, it appears to cause an overall decrease in Scribble abundance.
This is consistent with data from a large-scale LC-MS/MS analysis of
a collection of breast tumors we carried out recently and will describe
in a separate publication. In this data set, summarized in Figure W5
available online, CD74 and Scribble showed a clear negative correla-
tion: The tumors with the highest CD74 abundance showed lowest
Scribble abundance and vice versa. These data further corroborate the
link between CD74 overexpression and Scribble deregulation estab-
lished in our experiments with cell-based models and transient and
stable inducible overexpression of CD74.
Scribble is a potential tumor suppressor and its deregulation and
abnormal localization in breast tumors has been documented already
[9]. The protein plays a crucial role in the maintenance of epithelial
polarity [10,22,23]. It is known to interact with the mitogen-activated
protein kinases of the ERK family, apparently downregulating their
activation and ability to migrate to the nucleus [24,25]. As reported
in the study of Nagasaka et al., in normal epithelial cells, Scribble is
localized at the basolateral membrane and this is required for its ability
to inhibit G1-to-S transition [26].
Here, we show that overexpression of CD74, a frequently ob-
served phenomenon in breast cancer, is a direct cause for deregula-
tion of Scribble. This finding can explain why triple-negative breast
tumors overexpressing CD74 tend to be more aggressive and with a
heightened metastatic propensity. It also suggests that the pathwayinvolved in this mechanism could be a good target for developing
rationale-based therapies and companion diagnostics for the treat-
ment of triple-negative breast cancer.
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reveals subset-specific viral recognition in dendritic cells. Immunity 32, 279–289.Figure W1. Overexpression of CD74 in lymph node–metastatic triple-negative breast tumors. (Top) Formaldehyde-fixed section from a
tumor was stained with secondary antibody only (A); CD74 staining in a section from node-negative tumor showing positive staining in
infiltrating lymphocytes and negative malignant cells (B); CD74 staining in a node-positive triple-negative tumor showing strong cytoplasmic
staining of the malignant cells (C). (Bottom left) CD74 IHC scores for node-positive (n= 9) and node-negative (n= 10) tumors. Themean and
SEM are indicated by horizontal lines. The P value of .0409 was calculated by one-tailed nonparametric Mann-Whitney t test. A one-tailed
Fisher’s exact test assuming cut value of 5 returns a P value of .051. (Bottom right) CD74 and Scribble abundances in the membrane
fractions of cultured breast cancer cell lines and the HEK293s cell line. The abundance was estimated by the spectral count method in
triplicate LC-MS/MS analyses. CD74 spectral counts are plotted on the right y-axis. The protein was only detected in MDA-435-MB. Scribble
spectral counts are plotted on left y-axis. Vertical bars represent SDs. Only MS/MS spectra passing the 1% FDR threshold as calculated by
MaxQuant were included in the analysis. Scribble is barely detectable with one to two spectral counts in MDA-435-MB.
Figure W2. CD74 knockdown affects the wound healing in MDA-
435-MB. (A) Western blot analysis of CD74 abundance in cells trans-
fected with control DNA (left) and CD74 siRNA performed 18 hours
after transfection. (B) Bar graph is based on two replicate analyses.
(C) Wound healing assay with control and CD74 siRNA-transfected
cells. The assays were started 18 hours after transfection. Photo-
graphs were taken at 0, 16, and 30 hours.
Figure W3. (Top) Scribble peptides and phosphorylation sites detected in immunoprecipitated Scribble by high-resolution mass
spectrometry. The detected peptides are shown as boxed sequences highlighted in yellow. The three phosphopeptides affected by
CD74 overexpression are highlighted in blue with phosphoserines shown in red. (Left) Measured H /L ratios for the high-scoring Scribble
peptides (Andromeda score > 100) showing that the unmodified peptides center on a normalized H /L ratio of 1 (blue symbols). The three
phosphorylated peptides, shown with red symbols ± SD, are significantly decreased in the heavy Scribble molecules coming from CD74-
overexpressing cells. For each of the phosphopeptides, the Student’s two-tailed t test returns a P value that is lower than .0001 when
calculated against the normalized H /L ratios of the unmodified peptides shown with blue triangles.
Figure W4. Long-term overexpression of CD74 leads to a decrease of Scribble abundance as determined by Western blot analysis. (Left)
Scribble detection in lysates from uninduced TetR/TetO-CD74 cells and cells induced with tetracycline for 48 hours. (Right) Bar graph of
the integrated band intensities of Scribble determined by the infrared fluorescent scanner in two independent experiments. The intensities
were normalized against tubulin.
Figure W5. Label-free quantitation (LFQ) of CD74 and Scribble in
membrane isolates of 25 breast tumor biopsies. The membrane
proteins were isolated by the permeabilization and extraction pro-
cedure, digested with trypsin, and analyzed by LC-MS/MS as de-
scribed in Materials and Methods section. MaxQuant was used to
process the LC-MS/MS data and calculate LFQ as described in [1].
The nonparametric Spearman ρ and corresponding P values were
calculated in R using cor.test.
